{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:49:37Z","timestamp":1791503377803,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jns.2026.126208","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:09:45Z","timestamp":1791414585000},"page":"126208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Infections and the neuromuscular junction: From direct neurotoxicity to immune-mediated dysfunction"],"prefix":"10.1016","volume":"491","author":[{"given":"Christian","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mascolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Parrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.126208_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2024.102229","article-title":"A new era in neuromuscular junction research: current advances in self-organized and assembled in vitro models","volume":"87","author":"Nebol","year":"2024","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/ijms27031253","article-title":"New insights into neuromuscular junction biology: evidence from human and animal research","volume":"27","author":"Liang","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2026.126208_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.610964","article-title":"The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis","volume":"13","author":"Rodr\u00edguez Cruz","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2026.126208_bb0020","series-title":"Electrodiagnostic Medicine","first-page":"227","article-title":"Disorders of the neuromuscular junction","author":"Govindarajan","year":"2021"},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1941874414535215","article-title":"Peripheral nervous system manifestations of infectious diseases","volume":"4","author":"Brizzi","year":"2014","journal-title":"Neurohospitalist"},{"issue":"12","key":"10.1016\/j.jns.2026.126208_bb0030","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00415-025-13504-3","article-title":"The overlooked side of myasthenia gravis: the non-motor manifestations\u2014a comprehensive review","volume":"272","author":"Messina","year":"2025","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2026.126208_bb0035","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1007\/s10072-025-08128-4","article-title":"Prominent and fast response to eculizumab in myasthenic crisis: the potential as rescue therapy in refractory myasthenia gravis","volume":"46","author":"Messina","year":"2025","journal-title":"Neurol. Sci."},{"issue":"8","key":"10.1016\/j.jns.2026.126208_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2025.101972","article-title":"Neuromuscular junction toxins","volume":"71","author":"Randall","year":"2025","journal-title":"Disease-a-Month"},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf773","article-title":"Botulism Sequelae: A Systematic Review","volume":"13","author":"Kosenko","year":"2025","journal-title":"Open Forum Infect. Dis."},{"issue":"2","key":"10.1016\/j.jns.2026.126208_bb0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/ijms26020777","article-title":"Botulinum toxin: a comprehensive review of its molecular architecture and mechanistic action","volume":"26","author":"Kumar","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2026.126208_bb0055","series-title":"Botulinum Toxin Treatment","first-page":"11","article-title":"Structure and mechanism of function of botulinum neurotoxins: How does the toxin work","author":"Jabbari","year":"2024"},{"key":"10.1016\/j.jns.2026.126208_bb0060","series-title":"Handbook of Neurotoxicity","first-page":"1155","article-title":"Molecular mechanism and effects of Clostridial neurotoxins","author":"Singh","year":"2022"},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0065","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jnc.15330","article-title":"Tetanus and tetanus neurotoxin: from peripheral uptake to central nervous tissue targets","volume":"158","author":"Megighian","year":"2021","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.jns.2026.126208_bb0070","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.ajpath.2024.05.009","article-title":"Local tetanus begins with a neuromuscular junction paralysis around the site of tetanus neurotoxin release due to cleavage of the vesicle-associated membrane protein","volume":"194","author":"Fabris","year":"2024","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/toxins5010073","article-title":"Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms","volume":"5","author":"Hassel","year":"2013","journal-title":"Toxins (Basel)."},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0080","doi-asserted-by":"crossref","first-page":"29446","DOI":"10.1038\/srep29446","article-title":"Tick holocyclotoxins trigger host paralysis by presynaptic inhibition","volume":"6","author":"Chand","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0085","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.410260608","article-title":"Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue","volume":"26","author":"Aberer","year":"1989","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2026.126208_bb0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/ane.13071","article-title":"Autoantibodies in acquired myasthenia gravis: clinical phenotype and immunological correlation","volume":"139","author":"Nagappa","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2026.126208_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.12659\/AJCR.903108","article-title":"Comorbid human immunodeficiency virus (HIV) and muscle-specific kinase (MuSK) myasthenia gravis: a case report and literature review","volume":"18","author":"Sherpa","year":"2017","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.jns.2026.126208_bb0100","article-title":"When HIV meets MG: is immune reconstitution in the mix?","volume":"8","author":"Nair","year":"2025","journal-title":"Neuroimmunol. Rep."},{"key":"10.1016\/j.jns.2026.126208_bb0105","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.67511","article-title":"Seronegative myasthenia gravis: a rare disease triggered by SARS-CoV-2 or a coincidence?","author":"Castro Silva","year":"2024","journal-title":"Cureus"},{"issue":"56","key":"10.1016\/j.jns.2026.126208_bb0110","doi-asserted-by":"crossref","first-page":"95432","DOI":"10.18632\/oncotarget.20731","article-title":"Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?","volume":"8","author":"Cavalcante","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00126334-200203010-00012","article-title":"Detection of HTLV-I tax-rex and pol gene sequences of Thymus gland in a large Group of Patients with Myasthenia Gravis","volume":"29","author":"Manca","year":"2002","journal-title":"JAIDS J. Acq. Immun. Def. Syndr."},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0120","first-page":"e177","article-title":"Post-varicella myasthenia gravis","volume":"48","author":"Saha","year":"2007","journal-title":"Singapore Med. J."},{"issue":"1\u20132","key":"10.1016\/j.jns.2026.126208_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2005.08.013","article-title":"Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection","volume":"240","author":"Mori","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2026.126208_bb0130","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1007\/s10072-023-07002-5","article-title":"MuSK myasthenia gravis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a challenging diagnosis and therapeutic approach","volume":"44","author":"Carmillo","year":"2023","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00415-015-7639-1","article-title":"MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient","volume":"262","author":"Ragunathan","year":"2015","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0140","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.126208_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/213092","article-title":"Inflammation and Epstein-Barr virus infection are common features of myasthenia gravis Thymus: possible roles in pathogenesis","volume":"2011","author":"Cavalcante","year":"2011","journal-title":"Autoimmune Dis."},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","article-title":"Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein\u2013Barr virus infection","volume":"221","author":"Cavalcante","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.jns.2026.126208_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000117030","article-title":"Human T Lymphotropic virus type I associated myelopathy and myasthenia gravis: a possible association?","author":"Fukui","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2026.126208_bb0160","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.88163","article-title":"Coincidental coexistence of human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic Paraparesis and myasthenia gravis in a patient with chronic HTLV-1 infection: a case report","author":"Garma-Solis","year":"2025","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jns.2026.126208_bb0165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3201\/eid2505.181591","article-title":"Severe Myasthenic manifestation of leptospirosis associated with new sequence type of Leptospira interrogans","volume":"25","author":"Tomschik","year":"2019","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jns.2026.126208_bb0170","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4103\/0028-3886.103202","article-title":"Combined involvement of muscle, nerve, and myoneural junction following Leptospira infection","volume":"60","author":"Pradhan","year":"2012","journal-title":"Neurol. India"},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2014.11.022","article-title":"Myasthenia gravis and related disorders: pathology and molecular pathogenesis","volume":"1852","author":"Ha","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.jns.2026.126208_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7002a1","article-title":"Clinical guidelines for diagnosis and treatment of botulism, 2021","volume":"70","author":"Rao","year":"2021","journal-title":"MMWR Recomm. Rep."},{"issue":"2","key":"10.1016\/j.jns.2026.126208_bb0185","doi-asserted-by":"crossref","DOI":"10.56305\/001c.72707","article-title":"Botulism in the 21st Century: A Scoping Review","volume":"2","author":"Kobaidze","year":"2023","journal-title":"Journal of Brown Hosp. Med."},{"key":"10.1016\/j.jns.2026.126208_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ajem.2024.06.018","article-title":"High risk and low prevalence diseases: botulism","volume":"82","author":"Heilmann","year":"2024","journal-title":"Am. J. Emerg. Med."},{"issue":"8","key":"10.1016\/j.jns.2026.126208_bb0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/toxins12080509","article-title":"Foodborne botulism: clinical diagnosis and medical treatment","volume":"12","author":"Lonati","year":"2020","journal-title":"Toxins (Basel)."},{"issue":"suppl_1","key":"10.1016\/j.jns.2026.126208_bb0200","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/cid\/cix814","article-title":"Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks","volume":"vol. 66","author":"Rao","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mus.27370","article-title":"Neurophysiological patterns of acute and post-acute foodborne botulism","volume":"64","author":"Boccagni","year":"2021","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.jns.2026.126208_bb0210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMra1409755","article-title":"Clinical Management of Potential Bioterrorism-Related Conditions","volume":"372","author":"Adalja","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.NAJ.0000656308.84951.e5","article-title":"The medical treatment of botulism","volume":"120","author":"Scruth","year":"2020","journal-title":"AJN, American Journal of Nursing"},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12245-021-00375-4","article-title":"Early diagnosis and critical management of wound botulism in the emergency department: a single center experience and literature review","volume":"14","author":"Neeki","year":"2021","journal-title":"Int. J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11739-022-03182-8","article-title":"Botulism in emergency department","volume":"18","author":"Barbato","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.jns.2026.126208_bb0230","article-title":"Lyme disease associated neurological and musculoskeletal symptoms: a systematic review and meta-analysis","volume":"43","author":"Bushi","year":"2025","journal-title":"Brain Behav. Immun. Health"},{"issue":"2","key":"10.1016\/j.jns.2026.126208_bb0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00365540600818029","article-title":"Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies","volume":"39","author":"Finsterer","year":"2007","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.jns.2026.126208_bb0240","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.99366","article-title":"Seropositive myasthenia gravis triggered by Lyme disease: a case study of molecular mimicry","author":"Sardana","year":"2025","journal-title":"Cureus"},{"issue":"10425","key":"10.1016\/j.jns.2026.126208_bb0245","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(23)01381-8","article-title":"HIV epidemiology, prevention, treatment, and implementation strategies for public health","volume":"403","author":"Mody","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jns.2026.126208_bb0255","series-title":"Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century","first-page":"109","article-title":"NeuroAIDS, comorbid mood disorders and neuropsychiatric effects of antiretroviral therapy","author":"Rodriguez","year":"2024"},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0260","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1871527322666230330083708","article-title":"Neurological complications caused by human immunodeficiency virus (HIV) and associated opportunistic co-infections: a review on their diagnosis and therapeutic insights","volume":"23","author":"Balaji","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.jns.2026.126208_bb0265","first-page":"679","article-title":"Neurological involvement in patients with acute\/recent HIV-1 infection. A case-control study","volume":"23","author":"Ambrosioni","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2026.126208_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00775","article-title":"Management issues in myasthenia gravis patients living with HIV: a case series and literature review","volume":"11","author":"Heckmann","year":"2020","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2026.126208_bb0275","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.clineuro.2011.03.019","article-title":"HIV-associated myasthenia gravis and impacts of HAART: one case report and a brief review","volume":"113","author":"Hung","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0280","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/IM9.0000000000000031","article-title":"MuSK myasthenia gravis in an HIV-infected Chinese old man successfully treated with pyridostigmine","volume":"2","author":"Xie","year":"2020","journal-title":"Infectious Microbes and Diseases"},{"key":"10.1016\/j.jns.2026.126208_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.738813","article-title":"A comparison of clinical, electro-diagnostic, laboratory, and treatment outcome differences in a cohort of HIV-infected and HIV-uninfected patients with myasthenia gravis","volume":"12","author":"Moodley","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2026.126208_bb0290","article-title":"When myasthenia gravis meets autoimmunity: cause or confounder?","author":"Messina","year":"2025","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2026.126208_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.08.2008.0649","article-title":"Mild clinical expression of Lambert\u2013Eaton myasthenic syndrome in a patient with HIV infection","volume":"2009","author":"Truffert","year":"2025","journal-title":"BMJ Case Rep."},{"issue":"8","key":"10.1016\/j.jns.2026.126208_bb0300","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/v17081064","article-title":"SARS-CoV-2 infection and antiviral strategies: advances and limitations","volume":"17","author":"Soares","year":"2025","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0305","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41579-023-01003-z","article-title":"SARS-CoV-2 biology and host interactions","volume":"22","author":"Steiner","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jns.2026.126208_bb0310","article-title":"SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines","volume":"15","author":"Li","year":"2024","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.jns.2026.126208_bb0315","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s10072-020-04708-8","article-title":"Neuromuscular presentations in patients with COVID-19","volume":"41","author":"Paliwal","year":"2020","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0320","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s10072-021-05823-w","article-title":"Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review","volume":"43","author":"Rodrigues","year":"2022","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2026.126208_bb0325","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/jnnp-2020-323565","article-title":"Management of patients with generalised myasthenia gravis and COVID-19: four case reports","volume":"91","author":"H\u00fcbers","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0330","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JND-200520","article-title":"COVID-19 in refractory myasthenia gravis- a case report of successful outcome","volume":"7","author":"Ramaswamy","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"issue":"2","key":"10.1016\/j.jns.2026.126208_bb0335","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mus.26918","article-title":"<scp>COVID<\/scp> -19 in patients with myasthenia gravis","volume":"62","author":"Anand","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.126208_bb0340","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.33048","article-title":"A case report and literature review of new-onset myasthenia gravis after COVID-19 infection","author":"Chatterjee","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jns.2026.126208_bb0345","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00415-022-11472-6","article-title":"New-onset myasthenia gravis after SARS-CoV-2 infection: case report and literature review","volume":"270","author":"Tereshko","year":"2023","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0350","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2026.126208_bb0355","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41579-025-01181-y","article-title":"Epstein\u2013Barr virus pathogenesis and emerging control strategies","volume":"23","author":"M\u00fcnz","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"20","key":"10.1016\/j.jns.2026.126208_bb0360","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.jns.2026.126208_bb0365","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2012.11.003","article-title":"The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis","volume":"256","author":"Yin","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.jns.2026.126208_bb0370","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1099\/0022-1317-77-12-3077","article-title":"Epstein--Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection","volume":"77","author":"Roberts","year":"1996","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0375","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1016\/S2666-5247(23)00359-2","article-title":"Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease","volume":"5","author":"O\u2019Donnell","year":"2024","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/cjid\/8667755","article-title":"Epidemiology and clinical outcomes of HTLV-1: a comprehensive narrative review of endemic and nonendemic regions","volume":"vol. 2026","author":"Noori","year":"2026","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0385","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mus.20694","article-title":"Myasthenia gravis associated with HTLV-I infection and atypical brain lesions","volume":"35","author":"Lalive","year":"2007","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.jns.2026.126208_bb0390","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0022-510X(95)00173-Y","article-title":"Myasthenia gravis, acute transverse myelitis, and HTLV-I","volume":"133","author":"Ijichi","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126208_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.618021","article-title":"A systematic review of the potential implication of infectious agents in myasthenia gravis","volume":"12","author":"Leopardi","year":"2021","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0400","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2893.1996.tb00106.x","article-title":"Myasthenia gravis and hepatitis C virus infection","volume":"3","author":"Halfon","year":"1996","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/CND.0b013e3181d4a527","article-title":"Neuromuscular diseases associated with chronic hepatitis C virus infection","volume":"13","author":"St\u00fcbgen","year":"2011","journal-title":"J. Clin. Neuromuscul. Dis."},{"issue":"21","key":"10.1016\/j.jns.2026.126208_bb0410","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003782","article-title":"Myasthenia crisis induced by Pegylated-interferon in patient with chronic hepatitis C","volume":"95","author":"Baik","year":"2016","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0415","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp.64.6.820","article-title":"Untreated hepatitis C may provoke myasthenia gravis","volume":"64","author":"Reading","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"14","key":"10.1016\/j.jns.2026.126208_bb0420","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.0b013e3181d7d884","article-title":"Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis","volume":"74","author":"Cavalcante","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.126208_bb0425","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2013.12.018","article-title":"Thymoma-associated myasthenia gravis: on the search for a pathogen signature","volume":"52","author":"Cufi","year":"2014","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.jns.2026.126208_bb0430","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2026.126208_bb0435","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/08830738050200051501","article-title":"Postinfectious myasthenia gravis: report of two children","volume":"20","author":"Felice","year":"2005","journal-title":"J. Child Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2026.126208_bb0440","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2009.08.018","article-title":"Expanded TCR v\u03b2 subsets of CD8+ T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients","volume":"216","author":"Tackenberg","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0014183","article-title":"Neuroleptospirosis in patients presenting with primary central nervous system infection: a multicentre study","volume":"20","author":"Perera","year":"2026","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"7_Supplement_1","key":"10.1016\/j.jns.2026.126208_bb0450","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0001051644.93899.98","article-title":"Neurological manifestations of leptospirosis: a retrospective study from India","volume":"vol. 103","author":"Dixit","year":"2024","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2026.126208_bb0455","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neurol.2022.06.009","article-title":"Neuro-leptospirosis: experience from a tertiary center of North India","volume":"179","author":"Bismaya","year":"2023","journal-title":"Rev. Neurol. (Paris)"},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0460","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12879-017-2415-8","article-title":"Progressive cutaneous Cryptococcosis complicated with meningitis in a myasthenia gravis patient on long-term immunosuppressive therapy \u2013 a case report","volume":"17","author":"Huong","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"2b","key":"10.1016\/j.jns.2026.126208_bb0465","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1590\/S0004-282X2011000300031","article-title":"Myasthenia gravis complicated with cryptococcal meningitis after thymectomy and long-term immunosuppressive therapy","volume":"69","author":"Lorenzoni","year":"2011","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jns.2026.126208_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1653458","article-title":"Cryptococcosis in patients with myasthenia gravis: clinical characteristics and management strategy","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.jns.2026.126208_bb0475","first-page":"344","article-title":"Clinical-pathologic conference (cpc) - pulmonary insufficiency in Myasthenia Gravis patient","volume":"vol. 152","author":"Litachevsky","year":"2013","journal-title":"Harefuah"},{"key":"10.1016\/j.jns.2026.126208_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1324702","article-title":"New implications for prion diseases therapy and prophylaxis","volume":"17","author":"Liu","year":"2024","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2026.126208_bb0485","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1474-4422(20)30029-6","article-title":"New paradigms of clinical trial design for genetic prion diseases","volume":"19","author":"Aguzzi","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126208_bb0490","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phrs.2005.09.002","article-title":"Prion protein potentiates acetylcholine release at the neuromuscular junction","volume":"53","author":"Re","year":"2006","journal-title":"Pharmacol. Res."},{"issue":"1\u20132","key":"10.1016\/j.jns.2026.126208_bb0495","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3940(93)90811-X","article-title":"Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions","volume":"159","author":"Askanas","year":"1993","journal-title":"Neurosci. Lett."},{"issue":"17","key":"10.1016\/j.jns.2026.126208_bb0500","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1093\/hmg\/ddu171","article-title":"Prion protein facilitates synaptic vesicle release by enhancing release probability","volume":"23","author":"Robinson","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2026.126208_bb0505","series-title":"Prion Diseases","first-page":"239","article-title":"Function of PrPC as a copper-binding protein at the synapse","author":"Kretzschmar","year":"2000"},{"issue":"15","key":"10.1016\/j.jns.2026.126208_bb0510","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1128\/JVI.00378-14","article-title":"Axonal and Transynaptic spread of prions","volume":"88","author":"Shearin","year":"2014","journal-title":"J. Virol."},{"issue":"04","key":"10.1016\/j.jns.2026.126208_bb0515","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/ajm.AJM_77_18","article-title":"Creutzfeldt\u2013Jakob disease with unusual presentation of peripheral neuropathy and ophthalmoplegia","volume":"8","author":"Arwani","year":"2018","journal-title":"Avicenna J. Med."},{"issue":"5","key":"10.1016\/j.jns.2026.126208_bb0520","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mus.21849","article-title":"Creutzfeldt\u2013Jakob disease presenting as bulbar palsy","volume":"42","author":"Mittal","year":"2010","journal-title":"Muscle Nerve"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:05:30Z","timestamp":1791500730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26004909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":104,"alternative-id":["S0022510X26004909"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126208","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections and the neuromuscular junction: From direct neurotoxicity to immune-mediated dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126208"}}